Weijie Dai

507 citations
27 papers · 359 indexed · h-index 13
Topics
Cancer-related molecular mechanisms research (9 papers)RNA modifications and cancer (6 papers)MicroRNA in disease regulation (5 papers)
Partner nations
ChinaSwitzerlandHungary

In The Last Decade

Weijie Dai

24 papers receiving 357 citations

Peers

Weijie Dai
Comparison fields: 5 of 64
  • Molecular Biology 275
  • Cancer Research 183
  • Pulmonary and Respiratory Medicine 52
  • Oncology 42
  • Surgery 39
Replace Jiwei Gao with:
Jiwei Gao Sweden
Xiaohui Qian China
Jimin Min United States
Manuel Cabeza-Segura Spain
D. Roda Spain
Suan Sun China
Seth Noorbakhsh United States
Alexandra Faustino Portugal
Zhuoqi Liu China
Ingrid Hofland Netherlands
Weijie Dai relative to Jiwei Gao Sweden Jiwei Gao's profile →
Citations per field
00.5×3.3×
Jiwei Gao · 1×
Citations per year

Countries citing papers authored by Weijie Dai

Since Specialization
Citations

This map shows the geographic impact of Weijie Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijie Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijie Dai more than expected).

Fields of papers citing papers by Weijie Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijie Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijie Dai. The network helps show where Weijie Dai may publish in the future.

Co-authorship network of co-authors of Weijie Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Weijie Dai. A scholar is included among the top collaborators of Weijie Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijie Dai. Weijie Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 0
5 0
6 5
7 1
8 6
9 12
10 7
11 45
12 6
13 4
14 43
15 23
16 18
17 27
18 13
19
Association of -160A/C single nucleotide polymorphism in E-cadherin gene promoter region with colorectal cancer in China.
3
20 12

About Weijie Dai

Weijie Dai is a scholar working on Cancer Research, Gastroenterology and Speech and Hearing, having authored 27 papers that have together received 359 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Cancer Research (183 citations), Gastroenterology (24 citations) and Molecular Biology (275 citations). Weijie Dai has collaborated with scholars based in China, Switzerland and Hungary. Frequent co-authors include Xiaozhong Yang, Gang Ma, Song Wei, Qianjun Li, Han Wang, Menghui Zhang, Juan Zhang, Jiajie Zhou, Chengcheng Gao and Xiaoyu Zhang. Their work appears in journals such as The Science of The Total Environment, Journal of Hazardous Materials and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026